Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

3drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: pembrolizumab-based ×

pembrolizumab-based

This drug is selected. Its supporting articles are shown below.

pembrolizumab-based2

Articles mentioning pembrolizumab-based

2 articles · page 1 of 1

817 Intratumoral CCR8+CD4+FoxP3+ regulatory T cell infiltration predicts inferior clinical outcomes but superior immunotherapeutic responsiveness in the patients with gastric cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

94.7%

pembrolizumab pembrolizumab-based PD-1 inhibitor CCR8 antagonist Gastric cancer Fudan University GC Zhongshan Hospital

…nical outcomes but superior immunotherapeutic responsiveness to pembrolizumab in GC. Transcriptomic and phenotypic analyses revealed that tum…

PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1/CTLA-4 immunotherapies in NSCLC

jitc · abstract · 2025-12-05 · 1 matching annotations

90.9%

nivolumab ipilimumab Pembro pembrolizumab-based Nivo Nivo+Ipi Ipi NSCLC

…emotherapy, pembrolizumab-based chemoimmunotherapy (Pembro) and nivolumab plus ipilimumab with or without two cycles of platinum-doublet …